136 related articles for article (PubMed ID: 1601066)
1. The selective 5-HT2 receptor antagonist amperozide attenuates 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane-induced inhibition of male rat sexual behavior.
Klint T; Dahlgren IL; Larsson K
Eur J Pharmacol; 1992 Mar; 212(2-3):241-6. PubMed ID: 1601066
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
Albinsson A; Palazidou E; Stephenson J; Andersson G
Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
[TBL] [Abstract][Full Text] [Related]
3. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.
Chaouloff F; Laude D; Baudrie V
Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400
[TBL] [Abstract][Full Text] [Related]
4. DOI-induced inhibition of copulatory behavior in male rats: reversal by 5-HT2 antagonists.
Watson NV; Gorzalka BB
Pharmacol Biochem Behav; 1991 Jul; 39(3):605-12. PubMed ID: 1784589
[TBL] [Abstract][Full Text] [Related]
5. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
[TBL] [Abstract][Full Text] [Related]
6. 5-HT1C/5-HT2 receptor blockade prevents 1-(2,5-dimethoxy-4-iodophenyl)2-aminopropane-, but not stress-induced increases in brain tryptophan.
Chaouloff F; Layeillon C; Baudrie V
Eur J Pharmacol; 1993 Jan; 231(1):77-82. PubMed ID: 8095238
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.
Bagdy G; Kalogeras KT
Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526
[TBL] [Abstract][Full Text] [Related]
8. (+/-)-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane(DOI) and alpha-methyl-5-HT: 5-HT2 receptor agonistic action on phosphatidylinositol metabolism in the rat fronto-cingulate and entorhinal cortex.
Edwards E; Ashby CR; Wang RY
Neuropharmacology; 1992 Jul; 31(7):615-21. PubMed ID: 1407401
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
Bagdy G; Sved AF; Murphy DL; Szemeredi K
Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
[TBL] [Abstract][Full Text] [Related]
10. Evidence for involvement of 5-HT1C and 5-HT2 receptors in the food intake suppressant effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
Aulakh CS; Hill JL; Yoney HT; Murphy DL
Psychopharmacology (Berl); 1992; 109(4):444-8. PubMed ID: 1365860
[TBL] [Abstract][Full Text] [Related]
11. Neonatal organizational effects of the 5-HT2 and 5-HT1A subsystems on adult behavior in the rat.
González MI; Albonetti E; Siddiqui A; Farabollini F; Wilson CA
Pharmacol Biochem Behav; 1996 May; 54(1):195-203. PubMed ID: 8728558
[TBL] [Abstract][Full Text] [Related]
12. 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI) exerts an anorexic action that is blocked by 5-HT2 antagonists in rats.
Schechter LE; Simansky KJ
Psychopharmacology (Berl); 1988; 94(3):342-6. PubMed ID: 3128809
[TBL] [Abstract][Full Text] [Related]
13. Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo.
Done CJ; Sharp T
Br J Pharmacol; 1992 Sep; 107(1):240-5. PubMed ID: 1422575
[TBL] [Abstract][Full Text] [Related]
14. Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI.
Arnt J; Hyttel J
Eur J Pharmacol; 1989 Feb; 161(1):45-51. PubMed ID: 2524390
[TBL] [Abstract][Full Text] [Related]
15. Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors.
Mazzola-Pomietto P; Aulakh CS; Wozniak KM; Hill JL; Murphy DL
Psychopharmacology (Berl); 1995 Jan; 117(2):193-9. PubMed ID: 7753967
[TBL] [Abstract][Full Text] [Related]
16. 5-HT and carbohydrate suppression: effects of 5-HT antagonists on the action of d-fenfluramine and DOI.
Lawton CL; Blundell JE
Pharmacol Biochem Behav; 1993 Oct; 46(2):349-60. PubMed ID: 8265689
[TBL] [Abstract][Full Text] [Related]
17. Evidence for involvement of 5-HT2 and 5-HT1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenyl aminopropane)-2 (DOI).
Pranzatelli MR
Neurosci Lett; 1990 Jul; 115(1):74-80. PubMed ID: 2216059
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
19. 5-HT2/5-HT1C receptor-mediated facilitatory action on unit activity of ventral horn cells in rat spinal cord slices.
Yamazaki J; Fukuda H; Nagao T; Ono H
Eur J Pharmacol; 1992 Sep; 220(2-3):237-42. PubMed ID: 1358651
[TBL] [Abstract][Full Text] [Related]
20. Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs.
Jäkälä P; Sirviö J; Koivisto E; Björklund M; Kaukua J; Riekkinen P
Eur J Pharmacol; 1995 Aug; 282(1-3):39-55. PubMed ID: 7498288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]